OVERWEIGHT AND OBESE ADULTS
Clinical trials for OVERWEIGHT AND OBESE ADULTS explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT AND OBESE ADULTS trials appear
Sign up with your email to follow new studies for OVERWEIGHT AND OBESE ADULTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin B3 shows promise against fatty liver disease in new trial
Disease control Recruiting nowThis study tests whether a daily dose of nicotinamide (a form of vitamin B3) can stop or reverse liver scarring (fibrosis) in people with fatty liver disease. Thirty overweight or obese adults with liver scarring will take either nicotinamide or a placebo for one year. Researcher…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
App-Based dietitian support aims to tackle obesity in new pilot study
Disease control Recruiting nowThis study tests a smartphone app that connects adults with obesity to a dietitian for personalized support. Over six months, participants track their weight and waist size, and answer questions about eating habits and health. The goal is to see if this digital approach helps peo…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: NA • Sponsor: Eatit AB • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New drug SYNT-101 enters early safety testing in humans
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, SYNT-101, to see if it is safe and how the body processes it. The study involves 64 healthy adults, including some who are overweight or have obesity. Participants will receive either the drug or a placebo, and researchers will monito…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: PHASE1 • Sponsor: Syntis Bio • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC